newsfilter
← Latest News
GlobeNewswire·

AIM ImmunoTech Secures New State-of-the-Art Facility for Product Development and Testing

OCALA, Fla., June 21, 2022 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AMERICAN) ("AIM" or the "Company"), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and vir